Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
26 August 2020 | Story Xolisa Mnukwa | Photo Pixabay

Mental health is a crucial component for a healthy and happy life, as it directly affects how we think, feel, and behave. Mental health also determines how we manage stress, cope with challenges, relate to others, and contribute to our community.  

As noted in the University of the Free State (UFS) #WellbeingWarriors campaign, heightened negative emotions during the COVID-19 pandemic are normal. You might experience feelings of anxiety, fear, sadness, helplessness, anger, and confusion. Your thoughts can also increase negative emotions, but thoughts are not always reality. Therefore, it is best to educate yourself.

According to Dr Melissa Barnaschone – UFS Director for Student Counselling and Development (SCD), the South African Depression and Anxiety Group (SADAG) will establish and enhance the mental-health support services offered by SCD and Careways as from 1 September 2020 in the following ways: 

- SADAG will extend SCD services by offering a dedicated UFS student mental health careline, which is free and accessible 24/7 to all UFS students. This will ensure that a constant means of mental-health support is available to UFS students. 

- Careways will serve as an extension of the emergency services offered by SCD.

Dr Barnaschone further explained that SADAG is working closely with the university to assist identified students, who will benefit from longer-term counselling offered by the SCD in order to continue with their therapeutic process. SADAG will also offer further support to students while they wait for their appointments with SCD.

This helpline will provide containment, crisis intervention, and support, as well as referrals to mental-health professionals and other psychosocial resources for all students on all the UFS campuses. 
students also have the option to contact SADAG by email or SMS for counselling assistance. 

Counselling for both the SADAG and Careways services will be available in the various South African languages.

Dr Barnaschone reiterated that the SCD will continue with all the services and resources currently offered by the department, and that these additional counselling services will serve as an extension of the SCD, assisting them with patient capacity and reducing the waiting period for students to receive adequate mental-health support and counselling. 

“As we are all navigating the uncertainties and changes that are taking place within our environments, it is vital to remember that we are all human and that we are feeling overwhelmed, stressed, or anxious. We need to keep reminding ourselves and each other that this is not a hopeless situation, and when we feel that we need help, all we need to do is ask for it. We are all here to support each other,” encouraged Dr Barnaschone.



News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept